The syringe closure system Vetter-Ject® is the innovative packaging solution from Vetter for highly-sensitive compounds
Recent market reports demonstrate rapid growth in the global market for prefilled syringe systems due largely to biologic drug development. Product differentiation early in drug development is critical to staying competitive. Innovative packaging developments, such as Vetter-Ject®, are making this easier, especially for more highly complex, advanced therapies.
Vetter-Ject® is a novel patented syringe closure system. With this closure part a baked-in siliconization of an integrated needle syringe can be realized. That allows the use with highly-sensitive compounds such as biologics. The tamper-evident closure system, combined with an integrated staked needle, supports the product integrity of Vetter-Ject®. During the development of Vetter-Ject® particular emphasis was laid on the usability.
Join Vetter for a live webcast on primary packaging challenges for biologics, the variety of options, and customizable features available to help meet specific needs of customers and their products today, and in the future.
The live event will answer the following questions, and more:
• What factors are affecting growth of the market for prefilled syringe systems, and what is the impact of these factors for your product development?
• What are the challenges for biologics in a growing prefilled syringes market, particularly in primary packaging?
• Which primary packaging options exist for prefilled syringes, and what are the advantages of using syringes early in the development stage?
This webinar will be presented live twice at:
- 8AM London/4PM Shanghai
- 3PM London/10AM New York
Please register for the most suitable time.
Presented by
Kevin J. Wrigley,
Product and Service Manager
Kevin J. Wrigley earned his MSc in International Business from the University of Ulster, UK in 2009. At Vetter, he is responsible for managing the commercial manufacturing business as it pertains to the product lifecycle and portfolio management perspective. Kevin began his career in the medical device and pharmaceutical industries in management positions at Smith & Nephew, and MorphoSys. He joined Vetter International in 2013 as Product & Service Manager.
Tilman Roedle,
Director Packaging Development
Tilman Roedle earned Master in Mechanical Engineering at the University of Stuttgart, Germany in 1995, focusing his studies on key aspects of design and materials’ sciences. Tilman began his career at Vetter Pharma in 2003 as Project Manager, Packaging Development. He was named Director, Packaging Development in 2005. In this position, Tilman is responsible for the development of primary packaging materials for parenterals and drug delivery systems, primary and secondary packing implementation, and process qualification to help ensure cGMP. Tilman began his career in Project Management in 1997 for special machinery investment projects supplied to the automotive industry.
